Literature DB >> 18636211

Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.

Lovisa Farnebo1, Fredrik Jerhammar, Linda Vainikka, Reidar Grénman, Lena Norberg-Spaak, Karin Roberg.   

Abstract

The present study was aimed at establishing a method that combines multiple factors of protein and genetic changes that enables prediction of radiosensitivity in the head and neck squamous cell carcinoma (HNSCC) cell lines. In nine HNSCC cell lines, the quantity of protein expression and the type of genetic alterations were translated into a point system, called the Number of Negative Points. The expression of 14 proteins involved in growth control and/or apoptosis was quantified using a densitometric assessment of Western blots. The blots were adjusted to actin and standardised to normal oral keratinocytes classifying them into four groups depending on the amount of protein expressed (0-3 points). Mutations of the p53 gene were classified into three groups and each mutation was given one point. Since the cell lines each had a known intrinsic radiosensitivity, a multivariate statistical calculation could then be performed to select for the combination of factors having the strongest correlation to radiosensitivity. The strongest correlation of the investigated factors was the combination of epidermal growth factor receptor, survivin and splice site/missense p53 mutations (R=0.990 and P<0.0001). No single factor had a significant correlation to the intrinsic radiosensitivity. Since a significant correlation to the intrinsic radiosensitivity was achieved only when two or more factors were combined, we conclude that a method such as the Number of Negative Points is necessary for prediction of treatment response. We present a novel method to combine factors which enables the prediction of radiosensitivity of HNSCC cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636211

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.

Authors:  Xiefeng Wang; Lili Huang; Yanjie Xu; Zhumei Shi; Yingyi Wang; Junxia Zhang; Xirui Wang; Lei Cao; Hui Luo; Jiawei Chen; Ning Liu; Yongmei Yin; Yongping You
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

2.  PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy--a study in a Swedish rectal cancer trial of preoperative radiotherapy.

Authors:  Annica Holmqvist; Jingfang Gao; Birgitta Holmlund; Gunnar Adell; John Carstensen; Dianne Langford; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2012-02-10       Impact factor: 4.430

3.  Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association.

Authors:  David M Vossen; Caroline V M Verhagen; Reidar Grénman; Roelof J C Kluin; Marcel Verheij; Michiel W M van den Brekel; Lodewyk F A Wessels; Conchita Vens
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

4.  A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.

Authors:  Linnea La Fleur; Ann-Charlotte Johansson; Karin Roberg
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.